OB_1170x120_9-14-20

Vasant Narasimhan

Novartis CEO Joseph Jimenez to step down

Novartis CEO Joseph Jimenez to step down

BASEL, Switzerland — Novartis chief executive officer Joseph Jimenez plans to retire from the company next year, to be succeeded by drug development chief Vasant Narasimhan. Plans call for Jimenez to step down on Jan. 31, 2018, and for Narasimhan, who is global head of drug development and chief medical officer at Novartis, to take